Search research articles
Contact Us
Filters
Showing results (1-10 of 159) with videos related to
Page
of 16
Sort By:
Clinical Pharmacokinetics
|
May 11, 2025
A Systematic Review and Classification of the Effects of P-glycoprotein Inhibitors and Inducers in Humans, Using Digoxin, Fexofenadine, and Dabigatran as Probe Drugs
Claire Coumau, Chantal Csajka
Journal of Pharmacokinetics and Pharmacodynamics
|
January 13, 2006
Pharmacokinetic-pharmacodynamic modelling: history and perspectives
Chantal Csajka, Davide Verotta
British Journal of Sports Medicine
|
May 12, 2016
Outbreak in meldonium positive laboratory tests: are we missing something?
Alice Panchaud, Chantal Csajka
Current HIV/AIDS Reports
|
September 15, 2006
Genetic, ethnic, and gender differences in the pharmacokinetics of antiretroviral agents
Margalida Rotger, Chantal Csajka, Amalio Telenti
Frontiers in Pharmacology
|
October 8, 2025
Implementing pharmacogenetic testing in community pharmacy practice: a scoping review
Aude Coumau, Claire Coumau, Chantal Csajka
Pharmaceutical Research
|
August 4, 2005
The use of a sum of inverse Gaussian functions to describe the absorption profile of drugs exhibiting complex absorption
Chantal Csajka, David Drover, Davide Verotta
Pharmacogenomics
|
June 15, 2007
ADME pathway approach for pharmacogenetic studies of anti-HIV therapy
Rubin Lubomirov, Chantal Csajka, Amalio Telenti
Journal of Clinical Pharmacology
|
October 26, 2020
Parametric Approaches in Population Pharmacokinetics
Monia Guidi, Chantal Csajka, Thierry Buclin
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 29, 2018
Reply to L. Pala et al
Anna Dorothea Wagner, Berna Özdemir, Chantal Csajka
Revue Medicale Suisse
|
November 10, 2017
[Detecting and assessing the impactof anticholinergic medications]
Chantal Csajka, Catherine Brémond, Pierre Olivier Lang
Page
of 16
Search research articles
Search
Showing results (1-10 of 159) with videos related to
Sort By:
Page
of 16
Clinical Pharmacokinetics
|
May 11, 2025
A Systematic Review and Classification of the Effects of P-glycoprotein Inhibitors and Inducers in Humans, Using Digoxin, Fexofenadine, and Dabigatran as Probe Drugs
Claire Coumau, Chantal Csajka
Journal of Pharmacokinetics and Pharmacodynamics
|
January 13, 2006
Pharmacokinetic-pharmacodynamic modelling: history and perspectives
Chantal Csajka, Davide Verotta
British Journal of Sports Medicine
|
May 12, 2016
Outbreak in meldonium positive laboratory tests: are we missing something?
Alice Panchaud, Chantal Csajka
Current HIV/AIDS Reports
|
September 15, 2006
Genetic, ethnic, and gender differences in the pharmacokinetics of antiretroviral agents
Margalida Rotger, Chantal Csajka, Amalio Telenti
Frontiers in Pharmacology
|
October 8, 2025
Implementing pharmacogenetic testing in community pharmacy practice: a scoping review
Aude Coumau, Claire Coumau, Chantal Csajka
Pharmaceutical Research
|
August 4, 2005
The use of a sum of inverse Gaussian functions to describe the absorption profile of drugs exhibiting complex absorption
Chantal Csajka, David Drover, Davide Verotta
Pharmacogenomics
|
June 15, 2007
ADME pathway approach for pharmacogenetic studies of anti-HIV therapy
Rubin Lubomirov, Chantal Csajka, Amalio Telenti
Journal of Clinical Pharmacology
|
October 26, 2020
Parametric Approaches in Population Pharmacokinetics
Monia Guidi, Chantal Csajka, Thierry Buclin
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 29, 2018
Reply to L. Pala et al
Anna Dorothea Wagner, Berna Özdemir, Chantal Csajka
Revue Medicale Suisse
|
November 10, 2017
[Detecting and assessing the impactof anticholinergic medications]
Chantal Csajka, Catherine Brémond, Pierre Olivier Lang
Page
of 16